74 related articles for article (PubMed ID: 4043950)
1. Pathogenesis of "fibrosis" in interstitial pneumonia: an electron microscopic study.
Katzenstein AL
Hum Pathol; 1985 Oct; 16(10):1015-24. PubMed ID: 4043950
[TBL] [Abstract][Full Text] [Related]
2. Cellular events in alveolitis and the evolution of pulmonary fibrosis.
Burkhardt A; Cottier H
Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 58(1):1-13. PubMed ID: 2574513
[TBL] [Abstract][Full Text] [Related]
3. Experimental study on fibrogenic effect of fur dust on rat lung.
Chen J; Cui Y; Sun Y; Lou J; Liu Z
Environ Health Prev Med; 2003 Jan; 7(6):292-4. PubMed ID: 21432399
[TBL] [Abstract][Full Text] [Related]
4. A roadmap to precision treatments for familial pulmonary fibrosis.
Hurley K; Ozaki M; Philippot Q; Galvin L; Crosby D; Kirwan M; Gill DR; Alysandratos KD; Jenkins G; Griese M; Nathan N; Borie R;
EBioMedicine; 2024 Jun; 104():105135. PubMed ID: 38718684
[TBL] [Abstract][Full Text] [Related]
5. Protective efficacy of pirfenidone in rats with pulmonary fibrosis induced by bleomycin.
Demirkol B; Gul S; Cörtük M; Akanıl Fener N; Yavuzsan E; Eren R; Baydili KN; Çekmen MB; Cetinkaya E
Sarcoidosis Vasc Diffuse Lung Dis; 2023 Sep; 40(3):e2023036. PubMed ID: 37712376
[TBL] [Abstract][Full Text] [Related]
6. Acinar micromechanics in health and lung injury: what we have learned from quantitative morphology.
Knudsen L; Hummel B; Wrede C; Zimmermann R; Perlman CE; Smith BJ
Front Physiol; 2023; 14():1142221. PubMed ID: 37025383
[TBL] [Abstract][Full Text] [Related]
7. Loss of IGFBP2 mediates alveolar type 2 cell senescence and promotes lung fibrosis.
Chin C; Ravichandran R; Sanborn K; Fleming T; Wheatcroft SB; Kearney MT; Tokman S; Walia R; Smith MA; Flint DJ; Mohanakumar T; Bremner RM; Sureshbabu A
Cell Rep Med; 2023 Mar; 4(3):100945. PubMed ID: 36787736
[TBL] [Abstract][Full Text] [Related]
8. Culture impact on the transcriptomic programs of primary and iPSC-derived human alveolar type 2 cells.
Alysandratos KD; Garcia-de-Alba C; Yao C; Pessina P; Huang J; Villacorta-Martin C; Hix OT; Minakin K; Burgess CL; Bawa P; Murthy A; Konda B; Beers MF; Stripp BR; Kim CF; Kotton DN
JCI Insight; 2023 Jan; 8(1):. PubMed ID: 36454643
[TBL] [Abstract][Full Text] [Related]
9. Small Airways in Idiopathic Pulmonary Fibrosis: Quiet but Not Forgotten.
Maher TM
Am J Respir Crit Care Med; 2021 Nov; 204(9):1010-1011. PubMed ID: 34554892
[No Abstract] [Full Text] [Related]
10. Patient-specific iPSCs carrying an SFTPC mutation reveal the intrinsic alveolar epithelial dysfunction at the inception of interstitial lung disease.
Alysandratos KD; Russo SJ; Petcherski A; Taddeo EP; Acín-Pérez R; Villacorta-Martin C; Jean JC; Mulugeta S; Rodriguez LR; Blum BC; Hekman RM; Hix OT; Minakin K; Vedaie M; Kook S; Tilston-Lunel AM; Varelas X; Wambach JA; Cole FS; Hamvas A; Young LR; Liesa M; Emili A; Guttentag SH; Shirihai OS; Beers MF; Kotton DN
Cell Rep; 2021 Aug; 36(9):109636. PubMed ID: 34469722
[TBL] [Abstract][Full Text] [Related]
11. Linking Fibrotic Remodeling and Ultrastructural Alterations of Alveolar Epithelial Cells after Deletion of
Engelmann TA; Knudsen L; Leitz DHW; Duerr J; Beers MF; Mall MA; Ochs M
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299227
[TBL] [Abstract][Full Text] [Related]
12. Distinctive pseudopalisaded histiocytic hyperplasia characterizes the transition of exudative to proliferative phase of diffuse alveolar damage in patients dying of COVID-19.
Kritselis M; Yambayev I; Prilutskiy A; Shevtsov A; Vadlamudi C; Zheng H; Elsadwai M; Ma L; Aniskovich E; Kataria Y; Higgins S; Sarita-Reyes C; Zuo T; Zhao Q; Quillen K; Burks EJ
Hum Pathol; 2021 Oct; 116():49-62. PubMed ID: 34273395
[TBL] [Abstract][Full Text] [Related]
13. Is Progression of Pulmonary Fibrosis due to Ventilation-induced Lung Injury?
Albert RK; Smith B; Perlman CE; Schwartz DA
Am J Respir Crit Care Med; 2019 Jul; 200(2):140-151. PubMed ID: 31022350
[No Abstract] [Full Text] [Related]
14. Epithelial Injury and Dysfunction in the Pathogenesis of Idiopathic PulmonaryFibrosis.
Winters NI; Burman A; Kropski JA; Blackwell TS
Am J Med Sci; 2019 May; 357(5):374-378. PubMed ID: 31010463
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase 4 inhibition reduces lung fibrosis following targeted type II alveolar epithelial cell injury.
Sisson TH; Christensen PJ; Muraki Y; Dils AJ; Chibucos L; Subbotina N; Tohyama K; Horowitz JC; Matsuo T; Bailie M; Nikam S; Hazama M
Physiol Rep; 2018 Jun; 6(12):e13753. PubMed ID: 29952109
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets.
Hewlett JC; Kropski JA; Blackwell TS
Matrix Biol; 2018 Oct; 71-72():112-127. PubMed ID: 29625182
[TBL] [Abstract][Full Text] [Related]
17. Using electron microscopes to look into the lung.
Ochs M; Knudsen L; Hegermann J; Wrede C; Grothausmann R; Mühlfeld C
Histochem Cell Biol; 2016 Dec; 146(6):695-707. PubMed ID: 27688057
[TBL] [Abstract][Full Text] [Related]
18. HGF Expressing Stem Cells in Usual Interstitial Pneumonia Originate from the Bone Marrow and Are Antifibrotic.
Gazdhar A; Susuri N; Hostettler K; Gugger M; Knudsen L; Roth M; Ochs M; Geiser T
PLoS One; 2013; 8(6):e65453. PubMed ID: 23840329
[TBL] [Abstract][Full Text] [Related]
19. Implicating exudate macrophages and Ly-6C(high) monocytes in CCR2-dependent lung fibrosis following gene-targeted alveolar injury.
Osterholzer JJ; Olszewski MA; Murdock BJ; Chen GH; Erb-Downward JR; Subbotina N; Browning K; Lin Y; Morey RE; Dayrit JK; Horowitz JC; Simon RH; Sisson TH
J Immunol; 2013 Apr; 190(7):3447-57. PubMed ID: 23467934
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
